It does not change how hungry you feel
For a comparison, see Ipamorelin vs CJC-1295
Hormone Replacement Therapy Consult $450 BPC-157 can be administered in several ways: Research and anecdotal reports suggest BPC-157 may: Although generally considered safe in research, reported side effects may include nausea, headaches, digestive issues, fatigue, appetite changes, fluid retention, dizziness, and fluctuations in blood sugar levels
It must be handled using standard aseptic technique by qualified researchers in compliance with applicable Irish and EU laboratory safety regulations and institutional guidelines
Tier 2: Partial Documentation Acceptable with Caution Criteria partially met: HPLC purity shown but no MS confirmation, in-house lab only, or COA not batch-specific
Finally, lebrikizumab-Ibkz may cause headaches in some people